Author: admin
USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular’s Paratope-PLUS™ CDR-Scanning
Data-Driven Technology Re-establishes a Pathway for Antibody Genus Claims that Meet US Patent Requirements Philadelphia – Integral Molecular, the industry leader in the discovery […]
What Tools Are Available for Specificity Testing During Drug Development?
Even though monoclonal antibodies are prized for their specificity, 1 in 3 lead candidates exhibit off-target binding. Because off-target interactions are so common and their safety consequences so large, we need accurate methods for identifying them. […]
Webinar Presented by Integral Molecular and IPWatchdog – Resurrecting Antibody Genus Protection: Allowed Claims Through CDR-Scanning
Thursday, March 5, 2026 12 pm ET View the recording New antibody patenting strategies, such as structure-based genus and means plus function claims, are […]
10x Faster Virus Neutralization Testing With Launch of Integral Molecular’s Ready Reporter Virus™ Kit
Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development Philadelphia – Integral Molecular, a leader in developing innovative tools for […]